4th International Symposium on Cancer Metastasis and the Lymphovascular System

简介(申请人提供)：第四届癌症转移和淋巴血管系统国际研讨会将于2011年5月13日至14日在纽约市举行，共9个主要会议。一个关于恶性黑色素瘤的进展：对治疗的影响的小型研讨会将在研讨会的前一晚举行。这9场会议将通过3场杰出的讲座得到加强。这些会议和杰出的讲座将表明，癌症转移是一个从原发部位到远处的渐进过程，通常是通过前哨淋巴结的门户。癌症患者可以根据基因组图谱和生物标记物分为不同的亚组，这对未来的研究和不断发展的治疗策略具有重要意义。生物标志物将被彻底检查，以确定其定义癌症转移的能力，并作为特定成像和治疗的目标。将促进基础科学家和临床医生之间的翻译对话，以便在了解癌症转移的分子机制和基础科学在遏制癌症扩散过程中的临床应用之间架起一座桥梁。本次研讨会的创新之处在于强调从小组讨论中提出未回答的问题，为未来的研究和临床试验产生新的假设。利用研讨会的主题，癌症转移是癌症研究和治疗的关键主题；我们希望制定一个强有力的青年研究人员和实习生奖励计划，让对癌症转移感兴趣的年轻研究人员和实习生积极参与研讨会。 与公共卫生相关：在美国，每四个美国人中就有一个被诊断出患有癌症，其中约50%的人的癌症可能会扩散，这将威胁到他们的生命。将于2011年5月12日至14日在纽约市举行的第四届国际癌症转移和淋巴血管系统研讨会：理性治疗的基础将讨论临床肿瘤学中这一紧迫的问题，主要主题是描述生物标记物用于跟踪癌症扩散和作为治疗目标的效用。已经努力吸引年轻的研究人员和实习生发展他们对癌症转移的职业兴趣。

DESCRIPTION (provided by applicant): There will be a total of 9 main sessions in the 4th International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy to be held from May 13-14, 2011 in New York City. A mini-symposium on Progression of Malignant Melanoma: Implications for Treatment will be held in the evening preceding the symposium. The 9 sessions will be enhanced by 3 distinguished lectures. These sessions and distinguished lectures will demonstrate that cancer metastasis is a progressive process from the primary site to the distant sites, oftentimes, via the gateway of the sentinel lymph nodes. Cancer patients can be classified into separate subgroups based on genomic profiles and biomarkers, with implications for future research and evolving treatment strategies. Biomarkers will be thoroughly examined for their ability to define cancer metastasis and as targets for specific imaging and therapy. A translational dialogue will be promoted between basic scientists and clinicians so that a bridge can be built between understanding the molecular mechanisms of cancer metastasis and clinical application of basic science in curbing the process of cancer spread. The innovative approach of this symposium is the emphasis to raise unanswered questions from the panel discussions to generate new hypotheses for future investigations and clinical trials. Using the theme of the symposium that cancer metastasis is a critical topic of cancer research and treatment; we want to develop a robust Young Investigator and Trainee Award Program to allow young investigators and trainees with interest in cancer metastasis to participate actively in the symposium. PUBLIC HEALTH RELEVANCE: In the United States, one of four Americans will be diagnosed with cancer and in about 50% of them, their cancer may spread, which will threaten their lives. The 4th International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy to be held from May 12-14, 2011 in New York City will address this urgent problem in clinical oncology with the major theme to describe the utility of biomarkers to track cancer spread and as targets for therapy. An effort has been made to attract young investigator and trainees to develop their career interest in cancer metastasis.